Schedule 13G ownership disclosure

CYBIN INC

Common Stock, no par value · CUSIP: 23256X100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLC

    Shares: 1,417,900.00 · Class: 2.8%

  • ORBIMED CAPITAL LLC

    Shares: 2,422,600.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-26-000189
Form type
SCHEDULE 13G
Filer
CYBIN INC.
CIK
CIK 1833141
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub